
Are You Asking These Seven Sexual Health Questions?
Romina Mauas, MD, one of the chapter's authors, is an outpatient physician at Hospital de Infecciosas F.J. Muñiz and a researcher at the Center for Studies for the Prevention and Control of Communicable Diseases at ISALUD University, Buenos Aires, Argentina.
'This content is entirely new. This highlights the key questions that should never be missed when taking a medical history. It also promotes an inclusive, respectful environment free from stigma, prejudice, or moral judgment while protecting privacy, confidentiality, and individual rights,' she said.
The chapter was co-authored with José Barletta, MD; Franco Bova, MD; Iael Altclas, MD; Adriana Basombrío, MD; Luciana Spadaccini, MD; Mara Huberman, MD; and Sergio Maulen, MD, PhD, all of whom are medical professionals.
'This material hasn't been available before, isn't covered in other guidelines, and can benefit any healthcare professional in the region,' said Alejandra Cuello, speaking with Medscape Spanish. She was one of the two coordinators of the recommendations. Cuello heads the Infectious Diseases Service at the Juan D. Perón Regional Polyclinic and was an adjunct professor of infectious diseases at the National University of Villa Mercedes, both in Villa Mercedes, Argentina.
The new guide included 21 chapters covering a wide range of topics, including urethritis, acquired syphilis, genital herpes, human papillomavirus, viral hepatitis, gonorrhea, Zika virus, sexual abuse and rape, STIs in pregnant women, and emerging STIs, such as mpox.
'Instead of just copying the international guidelines, this version includes local epidemiology, available diagnostic methods, and treatments tailored to the regional context,' Cuello said.
Patient Interaction
A unique feature of the updated guidelines is that they begin with recommendations on how to explore aspects of a patient's sexuality during consultations, an area often avoided due to 'lack of knowledge, modesty, or discomfort,' Cuello noted.
Mauas, speaking to Medscape Spanish said, 'We need to be warm because we are asking intimate questions. You cannot rush into conversations about sexual practices without creating a comfortable environment. She emphasized that a lack of empathy is often the first barrier to timely and appropriate care.
These guidelines highlighted the importance of the first interaction in building trust and obtaining the patient's accurate sexual history. Clinicians are encouraged to pay attention to initial greetings, maintain appropriate eye contact, and use supportive body language.
'Consultations should begin with open-ended questions. Clinicians are advised to first explore general concerns and then gradually move into more sensitive topics. Each question should be explained clearly using simple and respectful language. The approach should accommodate explicit sexual terms when necessary and be responsive to signs of anxiety or distress,' she said.
Core Components
The guidelines outlined seven key areas to consider in sexual health consultations.
Reason for consultation. Begin by understanding the reason for the patient's visit. Review any signs or symptoms to help guide the examination and diagnostic tests. History of STIs. Inquiring about a patient's history of STIs is important, as this can affect the current risk assessment, choice of diagnostic tests, and interpretation of results. 'Some people are aware of this; others are not because the infection may have been asymptomatic,' Mauas noted. Assess personal and partner(s) risk perception, including prior testing for HIV, viral hepatitis, and other STIs. Ask whether the patient has received postexposure prophylaxis for HIV, especially in the past 6-12 months. Sexual partners. Determine the time since the patient's last sexual contact. When possible, estimate the number of regular and casual partners in the past 3 months or during the 3-month period. Avoid making assumptions about a person's sexual orientation; instead, ask respectfully. 'What is your sexual desire? Do you like being with a woman or a man? What is your orientation? How do you perceive or define yourself?' Mauas explained. Sexual practices. Gather information about the sites of potential exposure and specific practices, including oral, vaginal (receptive/insertive), and anal (receptive/insertive). Also ask about group sex, transactional sex (in exchange for money, drugs, or services), use of sex toys, dating apps, and recreational drug use — including alcohol and sex-related substances. 'These are individual situations that need to be considered,' Mauas emphasized. STI protection. Ask about the frequency of condom use during vaginal or anal intercourse over the past 3 months. Discuss any barriers to condom use. In addition, the vaccination status for hepatitis A, hepatitis B, and human papillomavirus must be assessed. Pregnancy prevention. Discuss pregnancy planning, contraceptive use, and access to safe abortion services when relevant. If necessary, refer to the appropriate specialized health departments. 'Although it depends on the specialty, we can — and should — work together with the sexual and reproductive or nonreproductive health department, depending on what the patient wants, such as whether they need counseling on contraception,' Mauas said. Other sexual health issues. Screening for problems related to sexual satisfaction, function, or psychosexual concerns. Ask about experiences of gender-based violence and offer appropriate referrals to the relevant services. These guidelines also encourage clinicians to leave room for patients to raise additional personalized concerns.
Practical Recommendations
The guide outlines general recommendations for consultations with key populations and priority groups at a higher risk of STIs, including transgender people, sex workers, men who have sex with men, adolescents and young adults, incarcerated individuals, people who use drugs, and migrant populations.
The guide offered several recommendations to improve consultations, as follows.
Avoid making assumptions about sexual orientation. Ask open, respectful questions about sexual practices, such as the gender of sexual partners, relationship status, and whether the patient is monogamous.
Ask about self-identified gender at the beginning of the consultation to avoid mistakes or assumptions regarding sex or gender based on appearance. Gender-neutral languages should be used wherever possible. Ask questions such as, 'Are you taking any medication?' instead of 'Are you on any medication?'
Genital examination should be delayed unless clinically necessary. This can be postponed until a greater level of trust is established.
Recognize that not all individuals are sexually active or wish to initiate sexual practices.
Offer flexible services to accommodate different needs. For example, evening clinic hours may better serve those with nighttime work schedules.
Training the entire healthcare team to promote, inclusive stigma-free care is essential.
'Anyone who chooses to work in sexual health must be properly trained — not only in clinical knowledge but also in addressing personal biases that may come from cultural or religious beliefs. Primary care providers should familiarize themselves with these guidelines and build their capacity to manage consultations. If they are unable to complete the assessment, they should be referred appropriately; however, they must not become a barrier to care. When a patient feels mistreated due to administrative or bureaucratic hurdles, they often choose not to return,' Mauas said.
Mauas and Cuello reported having no relevant financial relationship.
This story was translated from Medscape's Spanish edition.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Menopause increases your risk of STIs due to how aging changes your body
Diagnoses for sexually transmitted infections, or STIs, are increasing in older adults. The Centers for Disease Control and Prevention reports the number of people older than 65 diagnosed with chlamydia, gonorrhea or syphilis in the U.S. increased about three-, five- and sevenfold, respectively, from 2010 to 2023. Data also suggests that women older than 50 are at greater risk for HIV than younger women. Explanations for why these infections are so common in older adults include limited understanding of STIs in this age group, infrequent condom use and increased availability of medications for conditions that typically limit sexual activity in older adults, such as like Viagra and Cialis for erectile dysfunction and estrogen creams and tablets for vaginal dryness. Many older adults are reluctant to discuss their sexual history with their partners and health care providers, which contributes to misconceptions that they are monogamous or sexually inactive. In my work as an infectious disease scientist, I examine the largely unexplored biological reasons for why postmenopausal women have increased susceptibility to STIs. My recently published research shows that menopause is associated with loss of the genital tract's protective barrier, an essential defense against the microbial pathogens that cause STIs. Menopause: A natural part of aging Menopause is the stage in a woman's life marked by no menstrual periods for 12 consecutive months. In the U.S., menopause begins on average between ages 45 and 55. It is estimated that by the year 2030, 1.2 billion women worldwide will be menopausal or postmenopausal. Menopause results from a loss of estrogen production from the ovaries, which can diminish vaginal lubrication and vaginal tissue elasticity. This can cause a condition called genitourinary syndrome of menopause, or GSM, which involves symptoms such as vaginal dryness and irritation, painful sex and frequent urinary tract infections. Roughly half of postmenopausal women experience GSM. In addition to these negative effects on vaginal health, research from my lab has found that menopause also compromises the structural integrity of the tissue lining the vagina. The surface of the vagina is composed of multiple layers of epithelial cells that are held together by numerous adhesion molecules, including the proteins desmoglein-1, or DSG1, and desmocollin-1, or DSC1. These proteins strengthen the vaginal lining and restrict pathogen access to deeper tissue, reducing the risk of infection. To explore how menopause affects the vaginal lining, we compared the DSG1 and DSC1 levels in vaginal tissue from postmenopausal and premenopausal women. We found significantly lower DSG1 and DSC1 levels in postmenopausal women. We then surgically removed the ovaries of mice to model the loss of ovarian estrogen production in postmenopausal women. We also detected significantly less DSG1 and DSC1 proteins in vaginal tissue from mice without ovaries compared with mice with intact ovaries. Mice without ovaries also had greater susceptibility to infection with herpes simplex virus type 2, or HSV-2, and were less able to clear chlamydia infection from their lower genital tract. On the other hand, applying estrogen cream to mice without ovaries restored the integrity of their vaginal lining and fully protected these mice from HSV-2 infection. Too important to ignore Fully understanding the behavioral and biological risk factors that contribute to STI susceptibility can help clinicians and public health officials tackle the startling increases in STIs among older adults. Together, our studies show there is a loss of integrity in the vaginal lining after menopause. While additional research is needed, findings from our lab suggest that estrogen-containing compounds used to relieve vaginal irritation and other symptoms of genitourinary syndrome of menopause can also reduce susceptibility to STIs among older adults. In the meantime, health care providers can help reduce the risk of STIs among older adults by consistently counseling them about safe sex practices and offering routine STI screening. This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Thomas L. Cherpes, The Ohio State University Read more: Millions of women are working during menopause, but US law isn't clear on employees' rights or employers' obligations Iceland's recent volcanic eruptions driven by pooling magma are set to last centuries into the future The sex of your cells matters when it comes to heart disease Thomas L Cherpes receives funding from the National Institute on Aging and the National Institute of Child Health and Human Development
Yahoo
3 days ago
- Yahoo
Justin Timberlake Reveals Lyme Disease Diagnosis: ‘Living With This Can Be Relentlessly Debilitating'
One day after closing out his Forget Tomorrow World Tour, Justin Timberlake has revealed that he was quietly suffering with Lyme disease throughout the trek. In a vulnerable Instagram post Thursday (July 31), the pop star shared photos from his time on the road and wrote, 'As I'm reflecting on the tour and festival tour — I want to tell you a little bit about what's going on with me.' More from Billboard Jelly Roll & Shaboozey to Headline Australia's Strummingbird Festival Roze Oficial, Max Carra, Valen & Ramky En Los Controles Rule Billboard Argentina Hot 100 Chart For Third Week With 'Tu Jardín Con Enanitos' Kesha Announces Australian Return With 2026 Tour Dates Timberlake went on to announce, 'Among other things, I've been battling some health issues, and was diagnosed with Lyme disease — which I don't say so you feel bad for me — but to shed some light on what I've been up against behind the scenes.' 'If you've experienced this disease or know someone who has — then you're aware: living with this can be relentlessly debilitating, both mentally and physically,' he continued. 'When I first got the diagnosis I was shocked for sure. But, at least I could understand why I would be onstage and in a massive amount of nerve pain or, just feeling crazy fatigue or sickness. I was faced with a personal decision. Stop touring? Or, keep going and figure it out. I decided the joy that performing brings me far outweighs the fleeting stress my body was feeling. I'm so glad I kept going.' According to the Mayo Clinic, Lyme disease is caused by borrelia bacteria, which is carried by some ticks. Humans who contract the illness usually do so after being bitten by one of those ticks, often in a wooded area. Symptoms of the disease include rashes, body pain and stiffness, muscle weakness and immune-system issues. Timberlake isn't the first musician who's publicly shared his Lyme diagnosis, with Shania Twain, Avril Lavigne, Justin Bieber and more stars also previously speaking about their struggles with the illness. Timberlake's post marks the end of more than a year of touring on his Forget Tomorrow trek, which kicked off in April 2024, about one month after he released album Everything I Thought It Was. The trek made Timberlake the 10th top touring artist of Billboard's midyear Boxscore report, grossing $73.2 million across 41 shows as of late of Billboard Chart Rewind: In 1989, New Kids on the Block Were 'Hangin' Tough' at No. 1 Janet Jackson's Biggest Billboard Hot 100 Hits H.E.R. & Chris Brown 'Come Through' to No. 1 on Adult R&B Airplay Chart Solve the daily Crossword


Medscape
3 days ago
- Medscape
New Biomarker May Predict Advancement to HCC in HIV/HCV
Individuals living with both HIV and hepatitis C virus (HCV) who ultimately developed hepatocellular carcinoma (HCC) showed greater suppression of plasma extracellular vesicles (pEVs) after HCV clearance than those who did not develop cancer, based on new data presented at the International AIDS Society Conference on HIV Science. The study is important because of the persistent risk for HCC among individuals with advanced fibrosis who clear HCV with direct-acting antivirals, said Ariel Osegueda, MSc, a PhD candidate and biologist at the University of Buenos Aires, Buenos Aires, Argentina, in an interview. pEVs are essential in immune modulation. Natural killer (NK) cells are essential for immune surveillance, particularly in targeting tumor cells, and CD107a (also known as lysosomal-associated membrane protein-1) is an indicator of cytotoxic activity. 'Understanding how natural killer cell function is modulated in this context may reveal mechanisms linked to that increased risk,' said Osegueda, who presented the findings at the meeting. The researchers collected plasma samples from 11 adults with advanced liver disease at baseline and after treatment with direct-acting antivirals. A total of five patients developed HCC after a median of 5.75 years after clearance. The researchers also assessed samples from six healthy control individuals. NK cell degranulation was assessed using flow cytometry. The pEV from individuals with advanced LF at baseline were significantly more suppressive than control individuals (0.71 vs 0.88; P = .023). By at least 1 year after direct-acting antiviral therapy, pEV in patients who developed HCC was significantly more suppressive than in those who did not develop HCC (0.75 vs 0.86; P = .008). In addition, the pEV among individuals who did not develop HCC was similar to control individuals, whereas pEV from those who ultimately developed HCC was more suppressive than control individuals ( P = .03). Overall, the presence of pEV from all study participants, including control individuals, reduced expression of NK CD107a expression compared to NK cells without pEV. NK suppression persisted over time in patients who developed HCC but decreased in those who did not. The researchers were particularly surprised by the persistent NK suppression seen in patients who developed HCC, Osegueda told Medscape Medical News . 'This suggests an early and lasting immune alteration not reversed by viral clearance,' she said. This study was limited by the small sample size, but there are implications for clinical practice, Osegueda said. 'Persistent NK dysfunction mediated by plasma extracellular vesicles could become a biomarker to identify patients at higher risk of hepatocellular carcinoma after HCV cure,' she said. However, larger studies are needed to confirm these findings, characterize the pEV content, and explore whether modulating NK function can reduce HCC risk, Osegueda added. Foundation for Future Studies 'The risk of HCC remains elevated for patients living with HIV who have liver fibrosis despite HCV cure,' said David J. Cennimo, MD, associate professor of medicine and pediatrics in the Division of Infectious Disease at Rutgers New Jersey Medical School, Newark, New Jersey, in an interview. In the current study, the researchers present early data that could help identify a risk factor for liver cancer, said Cennimo, who was not involved in the study. The study also sheds light on the impact of the immune system's surveillance in preventing cancer by closer examination of pEVs, he said. This study was funded by a grant from the National Agency for Research, Technological Development and Innovation (Argentina). The authors had no financial disclosures.